Interferon beta-1b

Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma

Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment

An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial

Double Therapy With IFN-beta 1b and Hydroxychloroquine

Dual Therapy With Interferon Beta-1b and Clofazimine for COVID-19

IFN Beta-1b and Ribavirin for Covid-19

IFN-beta 1b and Remdesivir for COVID19

Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen

STOP-I-SEP_Disease modifying therapies withdrawal in inactive Secondary Progressive Multiple Sclerosis patients older than 50 years

Natalizumab De-escalation With Interferon Beta-1b

Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple Sclerosis

Evaluate Safety/Tolerability in Portuguese Participants With RRMS Transitioning From Current Therapy

The Safety and Effectiveness of Ganciclovir Plus Interferon Beta in Preventing the Return of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS